Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Sep;41(3):303–307. doi: 10.1136/gut.41.3.303

Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital

C Macdonald 1, A Wicks 1, R Playford 1
PMCID: PMC1891490  PMID: 9378382

Abstract

Background—Barrett's metaplasia is a premalignant condition for which screening is recommended. 
Aims/methods—Annual screening endoscopies have been performed on all subjects suitable for surgery for many years. To examine the benefits to patients of continuing this policy 10 years' experience of screening for Barrett's oesophagus was reviewed. 
Results—Of the 29 374 endoscopies performed over this period, Barrett's metaplasia was present in 1.4%. There was an approximate equal sex distribution with the majority of cases being identified in patients over 50 years old. Thirty five per cent of these patients were suitable to enter a yearly screening programme. During screening, the length of oesophagus involved did not vary over time. As a result of 379 endoscopies performed for screening purposes, only one patient was identified as developing carcinoma solely as a result of the screening programme. Two further patients had carcinoma identified as a result of progressive dysphagia requiring additional endoscopies. All three patients who developed carcinoma while in the screening programme had "long segment" (>8 cm) regions of Barrett's metaplasia with a stricture present at the initial endoscopy. 
Conclusions—The poor yield from this screening programme suggests that the policy should be reconsidered. Resources may be better spent on focusing on patients who present with ulceration or stricture in addition to Barrett's metaplasia. 



Keywords: malignancy; endoscopy; oesophageal carcinoma

Full Text

The Full Text of this article is available as a PDF (117.0 KB).

Figure 1 .

Figure 1

Open in a new tab

: Number of new patients identified in our endoscopy unit as having Barrett's metaplasia present over the period 1984-1994. Black columns represent male patients and white columns female patients. 


Figure 2 .

Figure 2

Open in a new tab

: Age of patients at time of initial diagnosis of Barrett's metaplasia. Black columns represent male patients and white columns female patients. 


Figure 3 .

Figure 3

Open in a new tab

: Symptoms or clinical indication for the initial endoscopy which led to the recognition of the presence Barrett's metaplasia. Black columns represent male patients and white columns female patients. GORD, symptoms suggestive of gastro-oesophageal reflux. Review, repeat endoscopy to confirm healing of benign gastric ulceration where Barrett's metaplasia was not commented on at the initial endoscopy. 


Figure 4 .

Figure 4

Open in a new tab

: Pie chart showing the percentage of potentially suitable patients who entered the screening programme and the main reason for exclusion in the rest. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson M., Iftikhar S. Y., James P. D., Robertson C. S., Steele R. J. The early diagnosis of oesophageal adenocarcinoma by endoscopic screening. Eur J Cancer Prev. 1992 Jun;1(4):327–330. doi: 10.1097/00008469-199206000-00009. [DOI] [PubMed] [Google Scholar]
  2. BARRETT N. R. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg. 1950 Oct;38(150):175–182. doi: 10.1002/bjs.18003815005. [DOI] [PubMed] [Google Scholar]
  3. Bartlesman J. F., Hameeteman W., Tÿtgat G. N. Barrett's oesophagus. Eur J Cancer Prev. 1992 Jun;1(4):323–325. doi: 10.1097/00008469-199206000-00008. [DOI] [PubMed] [Google Scholar]
  4. Bonelli L. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee. Endoscopy. 1993 Nov;25(9):652–654. doi: 10.1055/s-2007-1010425. [DOI] [PubMed] [Google Scholar]
  5. Cameron A. J., Lomboy C. T. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992 Oct;103(4):1241–1245. doi: 10.1016/0016-5085(92)91510-b. [DOI] [PubMed] [Google Scholar]
  6. Cameron A. J., Ott B. J., Payne W. S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985 Oct 3;313(14):857–859. doi: 10.1056/NEJM198510033131404. [DOI] [PubMed] [Google Scholar]
  7. Cameron A. J., Zinsmeister A. R., Ballard D. J., Carney J. A. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990 Oct;99(4):918–922. doi: 10.1016/0016-5085(90)90607-3. [DOI] [PubMed] [Google Scholar]
  8. Chow W. H., Finkle W. D., McLaughlin J. K., Frankl H., Ziel H. K., Fraumeni J. F., Jr The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA. 1995 Aug 9;274(6):474–477. [PubMed] [Google Scholar]
  9. Clark G. W., Smyrk T. C., Burdiles P., Hoeft S. F., Peters J. H., Kiyabu M., Hinder R. A., Bremner C. G., DeMeester T. R. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg. 1994 Jun;129(6):609–614. doi: 10.1001/archsurg.1994.01420300051007. [DOI] [PubMed] [Google Scholar]
  10. Gray M. R., Donnelly R. J., Kingsnorth A. N. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut. 1993 Jun;34(6):727–731. doi: 10.1136/gut.34.6.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iftikhar S. Y., James P. D., Steele R. J., Hardcastle J. D., Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut. 1992 Sep;33(9):1155–1158. doi: 10.1136/gut.33.9.1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnston M. H., Hammond A. S., Laskin W., Jones D. M. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol. 1996 Aug;91(8):1507–1511. [PubMed] [Google Scholar]
  13. Lerut T., Coosemans W., Van Raemdonck D., Dillemans B., De Leyn P., Marnette J. M., Geboes K. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg. 1994 Apr;107(4):1059–1066. doi: 10.1007/978-4-431-68246-2_25. [DOI] [PubMed] [Google Scholar]
  14. Li H., Walsh T. N., Hennessy T. P. Carcinoma arising in Barrett's esophagus. Surg Gynecol Obstet. 1992 Aug;175(2):167–172. [PubMed] [Google Scholar]
  15. Löf L., Götell P., Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol. 1993 Feb;28(2):113–118. doi: 10.3109/00365529309096056. [DOI] [PubMed] [Google Scholar]
  16. Mason R. J., Bremner C. C. Motility differences between long-segment and short-segment Barrett's esophagus. Am J Surg. 1993 Jun;165(6):686–689. doi: 10.1016/s0002-9610(05)80788-3. [DOI] [PubMed] [Google Scholar]
  17. Menke-Pluymers M. B., Hop W. C., Dees J., van Blankenstein M., Tilanus H. W. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993 Aug 15;72(4):1155–1158. doi: 10.1002/1097-0142(19930815)72:4<1155::aid-cncr2820720404>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  18. Moghissi K., Sharpe D. A., Pender D. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg. 1993;7(3):126–131. doi: 10.1016/1010-7940(93)90034-9. [DOI] [PubMed] [Google Scholar]
  19. Moon M. R., Schulte W. J., Haasler G. B., Condon R. E. Transhiatal and transthoracic esophagectomy for adenocarcinoma of the esophagus. Arch Surg. 1992 Aug;127(8):951–955. doi: 10.1001/archsurg.1992.01420080085013. [DOI] [PubMed] [Google Scholar]
  20. Paraf F., Fléjou J. F., Potet F., Molas G., Fékété F. Esophageal squamous carcinoma in five patients with Barrett's esophagus. Am J Gastroenterol. 1992 Jun;87(6):746–750. [PubMed] [Google Scholar]
  21. Provenzale D., Kemp J. A., Arora S., Wong J. B. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol. 1994 May;89(5):670–680. [PubMed] [Google Scholar]
  22. Riddell R. H. Early detection of neoplasia of the esophagus and gastroesophageal junction. Am J Gastroenterol. 1996 May;91(5):853–863. [PubMed] [Google Scholar]
  23. Schnell T. G., Sontag S. J., Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci. 1992 Jan;37(1):137–143. doi: 10.1007/BF01308357. [DOI] [PubMed] [Google Scholar]
  24. Spechler S. J., Goyal R. K. Barrett's esophagus. N Engl J Med. 1986 Aug 7;315(6):362–371. doi: 10.1056/NEJM198608073150605. [DOI] [PubMed] [Google Scholar]
  25. Spechler S. J., Goyal R. K. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology. 1996 Feb;110(2):614–621. doi: 10.1053/gast.1996.v110.agast960614. [DOI] [PubMed] [Google Scholar]
  26. Spechler S. J., Robbins A. H., Rubins H. B., Vincent M. E., Heeren T., Doos W. G., Colton T., Schimmel E. M. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology. 1984 Oct;87(4):927–933. [PubMed] [Google Scholar]
  27. Stein H. J., Siewert J. R. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia. 1993;8(3):276–288. doi: 10.1007/BF01354551. [DOI] [PubMed] [Google Scholar]
  28. Streitz J. M., Jr, Andrews C. W., Jr, Ellis F. H., Jr Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg. 1993 Mar;105(3):383–388. [PubMed] [Google Scholar]
  29. Van der Veen A. H., Dees J., Blankensteijn J. D., Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut. 1989 Jan;30(1):14–18. doi: 10.1136/gut.30.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wright T. A., Gray M. R., Morris A. I., Gilmore I. T., Ellis A., Smart H. L., Myskow M., Nash J., Donnelly R. J., Kingsnorth A. N. Cost effectiveness of detecting Barrett's cancer. Gut. 1996 Oct;39(4):574–579. doi: 10.1136/gut.39.4.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. van der Burgh A., Dees J., Hop W. C., van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut. 1996 Jul;39(1):5–8. doi: 10.1136/gut.39.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES